S&P futures down 0.6% Wednesday morning after US equities gained Tuesday, led by small caps, tech, consumer discretionary, and energy, while cosmetics, pharma, and managed care lagged. Asian markets were mixed, with South Korea up over 1% and Hong Kong down nearly 1%. European markets slipped ~0.3%. Treasuries strengthened, bringing 10-year yields below 4.50%. The […]
ETFsector.com Daily Trading Outlook, February 5, 2025 Read More »
S&P futures are up 0.3% Tuesday morning after Monday’s selloff, where the Nasdaq 100 dropped 3% amid AI-related weakness, with NVDA losing nearly $600B in market value. Positive breadth emerged as investors rotated into staples, banks, healthcare, and other tech. Asian markets were mixed, with the Nikkei down 1.5%, while Hong Kong posted gains. European
ETFsector.com Daily Trading Outlook, January 28, 2025 Read More »
Merck & Co., Inc. has received a “Moderate Buy” average rating from twenty-one ratings firms covering the company, according to MarketBeat.
US equities closed higher on Monday, with the Dow rising 1.20%, the S&P 500 up 1.16%, and the Nasdaq gaining 1.16%. The Russell 2000 trailed with a 0.30% increase. This rebound came after a difficult week, where the S&P 500 suffered its worst performance since March and the Nasdaq saw its steepest drop since January.
ETFsector.com Daily Trading Outlook, September 10, 2024 Read More »
The XLV lost ground by moving sideways in June, unable to entice investors who were looking to add risk instead. The price action has been sideways since XLV peaked in February, and with a weak start to July trading, the pattern is taking on a distributional look.
Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, revealed that Robert M. Davis, chairman and CEO, along with Dr. Dean Y. Li, EVP, made an announcement today.
Merck will be attending the Goldman Sachs 45th Annual Global Healthcare Conference. Read More »
The transcript of Merck & Co., Inc.’s presentation at the BofA Securities 2024 Health Care Conference.
Merck & Co., Inc. attended the BofA Securities 2024 Healthcare Conference, as discussed in the transcript.
